Study Design Considerations Research protocols must specify exact dosing schedules and concentrations
Per the American Diabetes Association (ADA) Standards of Care in Diabetes2026, diagnosis is confirmed by one of four criteria: fasting plasma glucose 126 mg/dL, 2-hour plasma glucose 200 mg/dL during a 75-g OGTT, A1C 6.5% (using an FDA-approved CLIA-certified method), or a random plasma glucose 200 mg/dL in a patient with classic hyperglycemia symptoms
Support for Cellular Repair and Longevity: By activating sirtuins and aiding DNA repair, NAD+ is a key component in the body's natural defense against cellular aging
Bidirectional Communication Bidirectional communication manifests in multiple experimental paradigms: From brain to gut: Selye-type stress leading to gastroduodenal ulcers was counteracted by BPC-157, which modulated hypothalamic-pituitary-adrenal (HPA) axis function and vagal signaling
Clinicians prescribing BPC-157 should document the following in the medical record: the off-label nature of the prescription, the absence of human clinical trial data, the FDA's position on compounded BPC-157, the patient's prior treatment history with approved therapies, and the patient's written informed consent
Plausible hypotheses That is the tension at the heart of the current peptide boom: plausible biology can generate excitement long before it generates reliable clinical evidence